These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27823636)

  • 1. Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.
    Lorenzi E; Simonelli M; Santoro A
    Crit Rev Oncol Hematol; 2016 Nov; 107():1-13. PubMed ID: 27823636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of molecular targeted therapies to fertility and safety during pregnancy: a review of current knowledge and future needs.
    Lorenzi E; Simonelli M; Persico P; Dipasquale A; Santoro A
    Expert Opin Drug Saf; 2021 May; 20(5):503-521. PubMed ID: 33600273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer treatment and fertility: Effect of therapeutic modalities on reproductive system and functions.
    Vassilakopoulou M; Boostandoost E; Papaxoinis G; de La Motte Rouge T; Khayat D; Psyrri A
    Crit Rev Oncol Hematol; 2016 Jan; 97():328-34. PubMed ID: 26481950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in fertility preservation for pediatric cancer patients.
    Ginsberg JP
    Curr Opin Pediatr; 2011 Feb; 23(1):9-13. PubMed ID: 21157350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Options for fertility preservation in pediatric populations undergoing cancer chemotherapy.
    Martin JR; Patrizio P
    Pediatr Endocrinol Rev; 2009 Jan; 6 Suppl 2():306-14. PubMed ID: 19337186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male fertility-implications of anticancer treatment and strategies to mitigate gonadotoxicity.
    Ragheb AM; Sabanegh ES
    Anticancer Agents Med Chem; 2010 Jan; 10(1):92-102. PubMed ID: 19912104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility preservation in children and adolescents with cancer.
    Levine J
    Minerva Pediatr; 2011 Feb; 63(1):49-59. PubMed ID: 21311429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Managing cutaneous toxicities of targeted therapies].
    Kiyohara Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1597-602. PubMed ID: 23152009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in Clinical Trials Information Will Improve the Reproductive Health and Fertility of Cancer Patients.
    Dauti A; Gerstl B; Chong S; Chisholm O; Anazodo A
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):235-269. PubMed ID: 28207285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine prevention of chemotherapy-induced ovarian failure.
    Blumenfeld Z; Evron A
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer.
    Byrne J; Mulvihill JJ; Myers MH; Connelly RR; Naughton MD; Krauss MR; Steinhorn SC; Hassinger DD; Austin DF; Bragg K
    N Engl J Med; 1987 Nov; 317(21):1315-21. PubMed ID: 3683460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity of molecularly targeted agents.
    Hedhli N; Russell KS
    Curr Cardiol Rev; 2011 Nov; 7(4):221-33. PubMed ID: 22758623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian stimulation in young adult cancer survivors on targeted cancer therapies.
    Su HI; Connell MW; Bazhenova LA
    Fertil Steril; 2016 Nov; 106(6):1475-1478. PubMed ID: 27565250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infertility induced by cancer treatment: inappropriate or no information provided to majority of French survivors of cancer.
    Mancini J; Rey D; Préau M; Malavolti L; Moatti JP
    Fertil Steril; 2008 Nov; 90(5):1616-25. PubMed ID: 18054004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular toxicities of biological therapies.
    Ryberg M
    Semin Oncol; 2013 Apr; 40(2):168-77. PubMed ID: 23540742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation in women with CNS tumors.
    Tosoni A; Balestrini D; Brandes AA
    Expert Rev Anticancer Ther; 2017 May; 17(5):439-445. PubMed ID: 28395560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preservation for adolescent women with cancer.
    Fish JD
    Adolesc Med State Art Rev; 2012 Apr; 23(1):111-22, xi. PubMed ID: 22764558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility of testicular cancer patients after anticancer treatment--experience of 11 years.
    Molnár Z; Berta E; Benyó M; Póka R; Kassai Z; Flaskó T; Jakab A; Bodor M
    Pharmazie; 2014 Jun; 69(6):437-41. PubMed ID: 24974577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.